REZOLUTE
Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases. The company is advancing a diversified portfolio including RZ358 (Phase 2), an antibody for the ultra-orphan indication of Congenital HyperInsulinism (CHI), with an abbreviated path-to-market strategy; AB101 (Phase 1), a once-weekly injectable basal insulin with the potential to transform the treatment landscape in diabetes management by reducing the therapeutic burden for patients and improving compliance; and a Plasma Kallikrein Inhibitor (PKI) portfolio with two lead compounds, RZ402 targeting Diabetic Macular Edema (DME) and RZ602 targeting Hereditary Angioedema (HAE), an orphan indication.
REZOLUTE
Industry:
Biotechnology Diabetes Health Care Therapeutics
Founded:
2010-01-01
Address:
Louisville, Colorado, United States
Country:
United States
Website Url:
http://www.rezolutebio.com
Total Employee:
11+
Status:
Active
Contact:
(303) 222-2128
Email Addresses:
[email protected]
Total Funding:
311.6 M USD
Technology used in webpage:
SPF SSL By Default LetsEncrypt Wordpress Plugins Nginx Microsoft Exchange Online Amazon Office 365 Mail GoDaddy DNS Google
Similar Organizations
Aeglea BioTherapeutics
Aeglea BioTherapeutics is a clinical-stage biotechnology company that develops enzyme therapies for rare metabolic diseases.
Aimmune Therapeutics
Aimmune Therapeutics is a clinical-stage biopharmaceutical company that improves the lives of people with food allergies.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Cellular Biomedicine Group
CBMG is a clinical-stage biopharmaceutical firm engaged in the development of immunotherapies for cancers and stem cell therapies.
Chiasma
Chiasma is a biopharmaceutical company developing oral drugs for the treatment of orphan diseases.
Dynacure
Dynacure is a clinical-stage drug development company focused on improving the lives of patients with rare and orphan diseases.
G.I. Windows
G.I. Windows is a clinical-stage company developing the first fundamental breakthrough in surgical anastomotic technology.
Gamida Cell
Gamida Cell is an advanced cell therapy company committed to finding cures for patients with blood cancers and serious blood diseases.
Goldfinch Biopharma
Goldfinch is a clinical-stage biotech company focused on discovering and developing precision therapies for patients with kidney disease.
Gritstone Bio
Gritstone Oncology is a clinical-stage biotech company that develops tumor-specific cancer immunotherapies to fight multiple cancer types.
Kodiak Sciences
Kodiak is designing and developing novel therapies for the treatment of retinal disease.
Kures
Kures is a pre-clinical-stage biopharmaceutical startup that develops opioid-based treatments for depressive disorder.
Milestone Pharmaceuticals
Milestone Pharmaceuticals is a drug development company developing small molecule therapeutics for the treatment of cardiovascular diseases.
Modis Therapeutics
Modis Therapeutics is bringing disease-modifying therapies to patients with rare genetic diseases.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Xeris Pharmaceuticals
Xeris Pharmaceuticals is a pharmaceutical company that develops therapies for patients in endocrinology, neurology, and gastroenterology.
Current Employees Featured
Founder
Stock Details
Investors List
Armentum Partners
Armentum Partners investment in Post-IPO Debt - Rezolute
SLR Capital Partners
SLR Capital Partners investment in Post-IPO Debt - Rezolute
CAM Capital
CAM Capital investment in Post-IPO Equity - Rezolute
BVF Partners
BVF Partners investment in Post-IPO Equity - Rezolute
Federated Kaufmann Fund
Federated Kaufmann Fund investment in Post-IPO Equity - Rezolute
Surveyor Capital
Surveyor Capital investment in Post-IPO Equity - Rezolute
Aju Pharma
Aju Pharma investment in Post-IPO Equity - Rezolute
Medici Investment
Medici Investment investment in Post-IPO Equity - Rezolute
Ildong Pharmaceutical
Ildong Pharmaceutical investment in Post-IPO Equity - Rezolute
pH Pharma
pH Pharma investment in Post-IPO Equity - Rezolute
Key Employee Changes
| Date | New article |
|---|---|
| 2022-06-01 | Rezolute Announces Promotion of Brian Roberts, M.D. to Chief Medical Officer |
Official Site Inspections
http://www.rezolutebio.com
- Host name: 169.214.233.35.bc.googleusercontent.com
- IP address: 35.233.214.169
- Location: Mountain View United States
- Latitude: 37.4043
- Longitude: -122.0748
- Metro Code: 807
- Timezone: America/Los_Angeles
- Postal: 94043
More informations about "Rezolute"
About - Rezolute, Inc.
Earlier in his career Jeff was the head of global marketing at Insmed where he led the development and global commercialization of a novel first-in-class therapy for a rare, life- …See details»
For Patients - Rezolute, Inc.
Whether you have been diagnosed with a condition that leads to frequent hypoglycemia due to elevated insulin levels or you are a representative of a patient advocacy organization for these …See details»
Governance :: Rezolute, Inc. (RZLT)
Investor Relations. Oregon Office 2783 NW Lolo Drive Suite 150 Bend, OR 97703See details»
Rezolute - Crunchbase Company Profile & Funding
Rezolute is a clinical-stage biopharma specializing in the development of drug therapies for patients with metabolic and orphan diseases. The company is advancing a diversified portfolio including RZ358 (Phase 2), an antibody for …See details»
Rezolute, Inc. | LinkedIn
For more information, visit: www.rezolutebio.com. Rezolute, Inc. | 7,704 followers on LinkedIn. Rezolute is developing transformative therapeutics for rare and metabolic diseases. | Rezolute …See details»
Rezolute, Inc. (RZLT)
Nov 7, 2024 Investor Relations. Oregon Office 2783 NW Lolo Drive Suite 150 Bend, OR 97703See details»
Rezolute - Company Profile - Tracxn
4 days ago Rezolute - Biopharmaceutical company developing therapies for metabolic & orphan diseases. Public Company. Raised funding over 17 rounds from 10 investors. Founded by …See details»
Rezolute CEO and Key Executive Team | Craft.co
Rezolute's Chief Executive Officer & Founder is Nevan Charles Elam. Other executives include Jin Kim, Chairman; Gil Labrucherie, Director and 1 others. See the full leadership team at Craft.See details»
Rezolute, Inc. Information - RocketReach
Rezolute is a late-stage rare disease company focused on significantly improving outcomes for individuals with hypoglycemia caused by hyperinsulinism (HI). For more information, visit: …See details»
Rezolute, Inc. Overview | SignalHire Company Profile
By Q2 2021, Rezolute, Inc. has participated in at least 12 funding rounds and has raised a minimum of 152.9M. Funding decreased noticeable in Q2 2021 — by 11.0M compared to the …See details»
10-K: Annual report pursuant to Section 13 and 15(d)
Jun 30, 2024 Our website is located at www.rezolutebio.com. We file annual, quarterly, current reports, proxy statements and other information with the Securities and Exchange Commission …See details»
Contact Us - Rezolute, Inc.
General Inquiries [email protected]+1 (650) 206-4507 Patient [email protected] Investor [email protected] Media …See details»
Rezolute - Overview, News & Similar companies | ZoomInfo.com
Www.rezolutebio.com. Revenue $61.6 Million. Stock Symbol RZLT. Industry Business Services General Business Services . Most Recent Scoops. Sep 25 2024. Earnings. Sep 25 2024. …See details»
Rezolute Company Profile - Craft
Oct 29, 2024 Louisville, CO HQ. United States. 1450 Infinite Dr. Bend, OR. United States. 2783 NW Lolo Dr #150. Redwood City, CA. United States. 201 Redwood Shores Pkwy #315See details»
Rezolute Reports First Quarter Fiscal 2025 Financial Results and ...
Nov 7, 2024 For more information, visit www.rezolutebio.com. Forward-Looking Statements This release, like many written and oral communications presented by Rezolute and our authorized …See details»
Rezolute Inc. - Cruelty Free Investing
Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The …See details»
Join Us - Rezolute, Inc.
Honest: We are driven by a commitment to ethical research and transparent communication, ensuring that our innovations are built on a foundation of trust and integrity. We prioritize …See details»
Rezolute | Redwood City CA - Facebook
Rezolute, Redwood City, California. 191 likes · 4 were here. Rezolute is dedicated to developing transformative therapies for patients suffering from...See details»
Rezolute Reports Fourth Quarter and Full Year Fiscal 2024 Financial ...
Sep 19, 2024 For more information, visit www.rezolutebio.com. Forward-Looking Statements This release, like many written and oral communications presented by Rezolute and our …See details»